3rd Quarter - Report

COVIDIEN LP for COVIDIEN LP

Firm
Client
Income
—
Expenses
$470,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Economics/Economic Development ECN

H.R. 2052/S. 1023: Global Investments in American Jobs Act of 2013 (all provisions)

Foreign entity interest: As the parent, Covidien PLC (as disclosed on the LD1) has an interest in the issues listed above.

LobbyistCovered position, as disclosed
WHITNEY GARDINER —

Contacted: State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Energy, Dept of; Office of Science & Technology Policy (OSTP); Executive Office of the President (EOP); SENATE; Food & Drug Administration (FDA)

Bills named: H.R. 2052 (113th), S. 1023 (113th)

Immigration IMM

Issues related to immigration reform.

Foreign entity interest: As the parent, Covidien PLC (as disclosed on the LD1) has an interest in the issues listed above.

LobbyistCovered position, as disclosed
TIMOTHY MCBRIDE —

Contacted: Office of Science & Technology Policy (OSTP); Energy, Dept of; State, Dept of (DOS); Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP)

Taxation/Internal Revenue Code TAX

S. 232: Medical Device Access and Innovation Protection Act (all provisions) ; H.R. 523: Protect Medical Innovation (all provisions); Issues related to the implementation of the Medical Device Tax; Issues related to the repeal of the Medical Device Tax; International tax on foreign direct investment; Corporate Tax Reform generally; S. 95: Student Loan Affordability Act of 2013 (provisions pertaining to international tax).

Foreign entity interest: As the parent, Covidien PLC (as disclosed on the LD1) has an interest in the issues listed above.

LobbyistCovered position, as disclosed
WHITNEY GARDINER —
JOHN CHRISTOPHER KALAVRITINOS —
TIMOTHY MCBRIDE —

Contacted: Energy, Dept of; SENATE; Executive Office of the President (EOP); Food & Drug Administration (FDA); State, Dept of (DOS); HOUSE OF REPRESENTATIVES; Office of Science & Technology Policy (OSTP)

Bills named: S. 232 (113th), S. 95 (113th), H.R. 523 (113th)

Health Issues HCR

Issues relating to sequestration of the medical device user fees; Issues related to reimbursements for Transcutaneous Electronic Stimulation (TENS) therapy for chronic low back pain; Issue regarding the Hospital Outpatient Prospective Payment System and the proposed changes to the reimbursement of certain vascular procedures.

Foreign entity interest: As the parent, Covidien PLC (as disclosed on the LD1) has an interest in the issues listed above.

LobbyistCovered position, as disclosed
WHITNEY GARDINER —
JOHN CHRISTOPHER KALAVRITINOS —
TIMOTHY MCBRIDE —

Contacted: Energy, Dept of; State, Dept of (DOS); Office of Science & Technology Policy (OSTP); Executive Office of the President (EOP); SENATE; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA)

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details. Other amounts

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.